XML 36 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

The following table presents revenue disaggregated by category (in thousands) for the years ended December 31, 2022 and 2021:


	Years Ended December 31,
	2022		2021
	(in thousands)
Eligibility-based	$	53,284	$	48,276
Claims-based	41,382		29,178
Healthcare Total	$	94,666	$	77,454
Recovery (1)	241		33,405
Customer Care / Outsourced Services	14,277		13,534
Total Revenues	$	109,184	$	124,393

(1) Represents student lending, state and municipal tax authorities, IRS and Department of Treasury markets, as well as Premiere.

Schedule of Details of Revenue by Major Customers

For the years ended December 31, 2022 and 2021, the Company had two and three different clients, respectively, whose individual revenues exceeded 10% of the Company’s total revenues. The dollar amount and percent of total revenue of each of the three clients are summarized in the table below (in thousands):


Year Ended December 31, 2022			Year Ended December 31, 2021
Rank	Revenue	Percent of total revenue	Rank	Revenue	Percent of total revenue
1	$58,155	53%	1	$55,471	45%
2	$12,004	11%	2	$15,893	13%
			3	$15,491	13%

Schedule of Reconciliation of Basic to Diluted Weighted Average Shares Outstanding

The following table reconciles the basic to diluted weighted average shares outstanding using the treasury stock method (shares in thousands):


	Years Ended December 31,
	2022	2021
Weighted average shares outstanding – basic	72,937	60,461
Dilutive effect of common share equivalents	—	—
Weighted average shares outstanding – diluted	72,937	60,461

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (shares in thousands):


	Years Ended December 31,
	2022	2021
Options to purchase common stock	250	1,593
RSUs	3,905	2,935
Warrants outstanding	—	6,310
Total	4,155	10,838